Skip to main content

Table 2 Incidence of CVD and death (percentage of participants) according to baseline diabetes and CVD status

From: Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

  New T2D, no CVD
(n = 933)
New T2D, CVD
(n = 98)
P-value Known T2D, no CVD
(n = 1138)
Known T2D, CVD
(n = 180)
P-value
New CVD events (%) 44 (4.7%) 25 (25.5%) < 0.001 66 (5.8%) 60 (33.3%) < 0.001
Death (%) 47 (5.0%) 16 (16.3%) < 0.001 47 (4.1%) 27 (15.0%) < 0.001
CVD or death (%) 88 (9.4%) 38 (38.8%) < 0.001 110 (9.7%) 77 (42.8%) < 0.001